Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease - A report of the NAPRTCS

被引:15
作者
Dharnidharka, Vikas R. [1 ]
Talley, Lynya I. [2 ]
Martz, Karen L. [2 ]
Stablein, Donald M. [2 ]
Fine, Richard N. [3 ]
机构
[1] Univ Florida, Coll Med, Div Pediat Nephrol, Gainesville, FL 32610 USA
[2] Emmes Corp, Rockville, MD USA
[3] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
关键词
growth hormone; post-transplant lymphoproliferative disease; kidney transplant;
D O I
10.1111/j.1399-3046.2007.00881.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
rhGH, widely used to optimize linear growth in children with ESRD, also modulates B-cell precursor development and may be associated with malignancy development. To determine if rhGH use in children was associated with higher risk of PTLD, we analyzed retrospectively collected data on children with CRI, on dialysis or with renal transplants in a large multi-center registry of children with ESRD. Of the 194 LPD patients currently listed in the registry, 41 were previously enrolled in the CRI registry and 18/41 (43.9%) used rhGH during their period with CRI. Among CRI patients who later received a transplant, rates of PTLD post-transplant were significantly higher among rhGH users (18/407 or 4.4%) compared to patients who never used rhGH during their CRI follow-up and received a transplant (23/1240 or 1.9%, p = 0.009). After adjusting for the confounders of recipient age (at CRI and at transplant) and transplant era, the use of rhGH pretransplant was associated with a borderline higher risk for PTLD (odds ratio 1.88, 95% CI = 1.00-3.55, p = 0.05). In contrast, use of rhGH during dialysis or post-transplant only was not associated with a higher risk for PTLD. Continued monitoring is recommended.
引用
收藏
页码:689 / 695
页数:7
相关论文
共 31 条
[1]   THE 1989 REPORT OF THE NORTH-AMERICAN-PEDIATRIC-RENAL-TRANSPLANT-COOPERATIVE-STUDY [J].
ALEXANDER, SR ;
ARBUS, GS ;
BUTT, KMH ;
CONLEY, S ;
FINE, RN ;
GREIFER, I ;
GRUSKIN, AB ;
HARMON, WE ;
MCENERY, PT ;
NEVINS, TE ;
NOGUEIRA, N ;
SALVATIERRA, O ;
TEJANI, A .
PEDIATRIC NEPHROLOGY, 1990, 4 (05) :542-553
[2]   Co-expression of GH and GHR isoforms in prostate cancer cell lines [J].
Chopin, LK ;
Veveris-Lowe, TL ;
Philipps, AF ;
Herington, AC .
GROWTH HORMONE & IGF RESEARCH, 2002, 12 (02) :126-136
[3]   Recombinant human insulin-like growth factor I (IGF-1): Risks and benefits of normalizing blood IGF-I concentrations [J].
Clark, RG .
HORMONE RESEARCH, 2004, 62 :93-100
[4]   Does the GH-IGF axis play a role in cancer pathogenesis? [J].
Cohen, P ;
Clemmons, DR ;
Rosenfeld, RG .
GROWTH HORMONE & IGF RESEARCH, 2000, 10 (06) :297-305
[5]   Post-transplant Lymphoproliferative disorder in the United States: Young Caucasian males are at highest risk [J].
Dharnidharka, VR ;
Tejani, AH ;
Ho, PL ;
Harmon, WE .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (10) :993-998
[6]   Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) [J].
Dharnidharka, VR ;
Sullivan, EK ;
Stablein, DM ;
Tejani, AH ;
Harmon, WE .
TRANSPLANTATION, 2001, 71 (08) :1065-1068
[7]   Recombinant rat and mouse growth hormones: Risk assessment of carcinogenic potential in 2-year bioassays in rats and mice [J].
Farris, Georgia M. ;
Miller, Glen K. ;
Wollenberg, Gordon K. ;
Molon-Noblot, Sylvain ;
Chan, Christine ;
Prahalada, Srinivasa .
TOXICOLOGICAL SCIENCES, 2007, 97 (02) :548-561
[8]   No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone [J].
Fiebig, HH ;
Dengler, W ;
Hendriks, HR .
ANTI-CANCER DRUGS, 2000, 11 (08) :659-664
[9]   Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry [J].
Fine, RN ;
Stablein, D .
PEDIATRIC NEPHROLOGY, 2005, 20 (03) :404-408
[10]   Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease [J].
Fine, RN ;
Ho, M ;
Tejani, A ;
Blethen, S .
JOURNAL OF PEDIATRICS, 2003, 142 (05) :539-545